细胞外代谢能量可以促进癌症的进展
Jia Min Loo1, Alexis Scherl1, Alexander Nguyen1
1Laboratory of Systems Cancer Biology, Rockefeller University, New York, NY 10065, USA.
Cell
|January 21, 2015
概括
两个微RNA,miR-551a和miR-483,通过向大脑类型 (CKB) 的肌酸激酶,抑制肝转移. 这些miRNAs或CKB抑制的治疗治疗减少了结直肠癌的传播,突出了新的代谢脆弱性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 代谢过程中的代谢.
背景情况:
- 大肠直肠癌经常转移到肝脏,每年造成超过60万人的死亡.
- 微RNAs (miRNAs) 在癌症的进展和转移中起着至关重要的作用.
- 代谢重编程是癌症的标志,支持瘤生长和生存.
研究的目的:
- 在结直肠癌中识别肝脏殖民和转移的内源性抑制剂.
- 阐明这些抑制剂调节癌细胞代谢的分子机制.
- 评估针对已识别的抑制剂或其下游效应物的治疗潜力.
主要方法:
- 在肝脏殖民期间对661个微RNA (miRNA) 的功能查.
- 通过miR-551a和miR-483.3研究肌酸激酶,脑型 (CKB) 的融合向.
- 评估细胞外CKB和肌酸载体SLC6A8在转移细胞ATP生成中的作用.
- 在体内评估miRNAs病毒传递和CKB抑制的治疗疗效.
主要成果:
- 确定miR-551a和miR-483是肝脏殖民和转移的强有力的抑制剂.
- 这些miRNAs向CKB,这是一种对脂蛋白产生至关重要的酶,为转移性ATP生成提供燃料.
- 在人肝转移中,细胞外CKB和SLC6A8被上调,而miR-551a/miR-483被下调.
- 在体内,miR-551a/miR-483或CKB抑制的治疗性输送显著抑制了转移.
结论:
- miR-551a和miR-483是结直肠癌肝脏转移的关键内源调节剂.
- 针对细胞外CKB介导的代谢途径是一个有前途的治疗策略.
- 细胞外空间是转移的代谢支持的关键部分,也是一个可行的治疗点.
相关概念视频
Adaptive Mechanisms in Cancer Cells
7.6K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.6K
Adaptive Mechanisms in Cancer Cells
4.4K
4.4K
The Tumor Microenvironment
8.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.3K
The Tumor Microenvironment
3.2K
3.2K
mTOR Signaling and Cancer Progression
5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression
1.8K
1.8K


